Trial Profile
From Immediate-release MPH to OROS MPH: The Impact Upon Family of Children and Adolescents With ADHD
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 May 2012
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary) ; Methylphenidate
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 18 Dec 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 18 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Feb 2008 New trial record.